Posted by Michael Wonder on 01 May 2019
Newly approved MS drug to offer relief to children
1 May 2019 - A wonder drug to treat children with multiple sclerosis has been approved for use in Australia.
Up to 10 per cent of MS sufferers are young people but until now they have had to use adult drugs for treatment often leaving them with uncomfortable side effects.
However, the substance fingolimod has been approved by the Therapeutic Goods Administration for use on younger patients, following a global study proving its positive effects in reducing relapses with less side effects.
